3LiVolsi V A,Mazzaferri E L,Schneider A B,et al.Papillary carcinoma[M]//DeLellis R A,Lloyd R V,Heitz P U,Eng C,et al,eds.World Health Organization classification of tumours,pathology and genetics of tumours of endocrine organs.Lyon:IARC Press,2004:57-66.
5Tunio GM,Hirota S,Nomura S,Kitamura Y.Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer[J].Arch Pathol Lab Med,1998,122(12):1087-90.
6Bai Y,Zhou G,Nakamura M,et al.Survival impact of psammoma body,stromal calcification,and bone formation in papillary thyroid carcinoma[J].Mod Pathol,2009,22(7):887-94.
7Johannessen J V,Sobrinho-Simoes M.The origin and significance of thyroid psammoma bodies[J].Lab Invest,1980,43(3):287-96.
8Nasr M R,Mukhopadhyay S,Zhang S,Katzenstein AL.Immunohistochemical markers in diagnosis of papillary thyroid carcinoma:Utility of HBME1 combined with CK19 immunostaining[J].Mod Pathol,2006,19(12):1631-7.
9Barroeta J E,Baloch Z W,Lal P,et al.Diagnostic value of differential expression of CK19,Galectin-3,HBME-1,ERK,RET,and p16 in benign and malignant follicular-derived lesions of the thyroid:an immunohistochemical tissue microarray analysis[J].Endocr Pathol,2006,17(3):225-34.
10Williams E D.Guest Editorial:Two Proposals Regarding the Terminology of Thyroid Tumors[J].Int J Surg Pathol,2000,8(3):181-3.
